Evidence map›Paper›PMID 30108876›Full record

ArticleMedChemComm2017

Design, synthesis, and biological evaluation of new thiazolo[5,4-

Zhong-Hua Li, Xue-Qi Liu, Peng-Fei Geng, Jin-Lian Ma, Tao-Qian Zhao, Hao-Ming Wei, Bin Yu, Hong-Min Liu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in MedChemComm, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zhong-Hua LiCollaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province , Key Laboratory of Technology of Drug Preparation (Zhengzhou University) , Ministry of Education of China , Key Laboratory of Henan Province for Drug Quality and Evaluation , School of Pharmaceutical Sciences , Zhengzhou University , Zhengzhou 450001 , PR China . Email: zzuyubin@hotmail.com ; Email: liuhm@zzu.edu.cn.
Xue-Qi LiuCollaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province , Key Laboratory of Technology of Drug Preparation (Zhengzhou University) , Ministry of Education of China , Key Laboratory of Henan Province for Drug Quality and Evaluation , School of Pharmaceutical Sciences , Zhengzhou University , Zhengzhou 450001 , PR China . Email: zzuyubin@hotmail.com ; Email: liuhm@zzu.edu.cn.
Peng-Fei GengCollaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province , Key Laboratory of Technology of Drug Preparation (Zhengzhou University) , Ministry of Education of China , Key Laboratory of Henan Province for Drug Quality and Evaluation , School of Pharmaceutical Sciences , Zhengzhou University , Zhengzhou 450001 , PR China . Email: zzuyubin@hotmail.com ; Email: liuhm@zzu.edu.cn.
Jin-Lian MaCollaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province , Key Laboratory of Technology of Drug Preparation (Zhengzhou University) , Ministry of Education of China , Key Laboratory of Henan Province for Drug Quality and Evaluation , School of Pharmaceutical Sciences , Zhengzhou University , Zhengzhou 450001 , PR China . Email: zzuyubin@hotmail.com ; Email: liuhm@zzu.edu.cn.
Tao-Qian ZhaoCollaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province , Key Laboratory of Technology of Drug Preparation (Zhengzhou University) , Ministry of Education of China , Key Laboratory of Henan Province for Drug Quality and Evaluation , School of Pharmaceutical Sciences , Zhengzhou University , Zhengzhou 450001 , PR China . Email: zzuyubin@hotmail.com ; Email: liuhm@zzu.edu.cn.
Hao-Ming WeiCollaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province , Key Laboratory of Technology of Drug Preparation (Zhengzhou University) , Ministry of Education of China , Key Laboratory of Henan Province for Drug Quality and Evaluation , School of Pharmaceutical Sciences , Zhengzhou University , Zhengzhou 450001 , PR China . Email: zzuyubin@hotmail.com ; Email: liuhm@zzu.edu.cn.
Bin YuCollaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province , Key Laboratory of Technology of Drug Preparation (Zhengzhou University) , Ministry of Education of China , Key Laboratory of Henan Province for Drug Quality and Evaluation , School of Pharmaceutical Sciences , Zhengzhou University , Zhengzhou 450001 , PR China . Email: zzuyubin@hotmail.com ; Email: liuhm@zzu.edu.cn.ORCID 0000-0002-0531-2236
Hong-Min LiuCollaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province , Key Laboratory of Technology of Drug Preparation (Zhengzhou University) , Ministry of Education of China , Key Laboratory of Henan Province for Drug Quality and Evaluation , School of Pharmaceutical Sciences , Zhengzhou University , Zhengzhou 450001 , PR China . Email: zzuyubin@hotmail.com ; Email: liuhm@zzu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A series of thiazolo[5,4-

Identifiers

PMID30108876
PMCPMC6071795

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.